Atlas Trials

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Clinical trial NCT00280969 · COMPLETED

Trial details

NCT number
NCT00280969
Sponsor
International Medical Center of Japan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infection
Start date
2005-09-01
Primary completion
2009-09-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.